Real-time Artificial Intelligence-based Speech Enhancement Methods for Hearing Aid Improvement

Recruiting N/A Interventional Study
Deafness Neurosensory
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
40 (estimated)
Sponsor
Institut Pasteur · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Individuals with Auditory Neuropathy Spectrum Disorders (ANSD) represent 1-10% of adults with hearing loss. These individuals have little or no benefit from current hearing aids because ANSD is a continuum of hearing impairments due to synaptic or neural dysfunction in the peripheral and central parts of the auditory pathways, which impairs temporal information processing without necessarily affec…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: For all participants: * Age greater than or equal to 18 years, * French mother tongue, * Have an average tonal hearing loss (calculated according to the BIAP method) \< 30 dB HL, on headphones, for each ear, * Be professionally active, not be pre-retired and not be unemployed *…
Contacts

Marta Campi, PhD

++33 (0) 1 76 53 51 12

marta.campi@pasteur.fr

CONTACT

Paul Avan, MD

+33 (0)1 76 53 50 94

paul.avan@uca.fr

CONTACT